Patent foramen ovale and stroke
Actual Tendencys
DOI:
https://doi.org/10.4181/RNC.2004.12.209Keywords:
Forame oval patente, Acidente vascular cerebral, AVCAbstract
Patent foramen ovale (PFO) occur in 10 to 15% in population. Recently PFO have been found in 45% of patients with cryptogenic stroke and in 23% of patients with atherosclerosis of large vessels. The exact mechanism of association of PFO and stroke is not established. The treatment of stroke and PFO may be clinical, or surgical. Recently percutaneous closure of PFO has been proposed.
Metrics
References
Lock JE. Patent foramen ovale is indicated, but the case hasn’t gone to trial. Circulation 2000; 101: 838.
Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale in the first 10 decades of life: in autopsy study of 965 normal hearts. Mayo Clin Proc 1984; 59: 17-20.
Steiner MM, Di Tulio MR, Rundek T, et al. Patent foramen ovale size and embolic brain imaging findings among patients ischemic stroke. Stroke 1998; 29: 944-948.
Mas JL, Zuber M. Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack. French Study Group on Patent Foramen Ovale and Atrial Septal Aneurysm. Am Heart J 1995; 130: 1083-1088.
Cujec B, Mainra R, Johnson DH. Prevention of recurrent cerebral ischemic events in patients with patent foramen ovale and cryptogenic strokes or transient ischemic attacks. Can J Cardiol 1999; 15: 57-64.
Overell JR, Bone I, Lees KR. Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology 2000; 55: 1172-1179.
Di Tulio M, Sacco RL, Venketasubramanian N, et al. Comparison of diagnostic techniques for the detection of a patent foramen ovale in stroke patients. Stroke 1993; 24: 1020-1024.
Di Tulio MR, Sacco RL, Gopal A, Mohr JP, Homma S. Patent foramen ovale as a risk factor for cryptogenic stroke. Ann Intern Med 1992; 117: 461-5.
Meier B, Lock JE. Contemporary Management of patent foramen ovale. Circulation 2003; 107: 5-9.
Homma S, Di Tulio MR, Sacco RL, Sciacca RR, Smith C, Mohr JP. Surgical closure of patent foramen ovale in cryptogenic stroke patients. Stroke 1997; 28: 2376-2381.
Mohr JP, Thompson JL, Lazar RM, Levin B, Sacco RL, Furie KL, Kistler JP, Albers GW, Pettigrew LC, Adams HP Jr, Jackson CM, Pullicino P; Warfarin-aspirin Recurrent Stroke Study Group. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med 2001; 345: 1444-1451.
Orgera MA, O’Malley PG, Taylor AJ. Secondary prevention of cerebral ischemia in patent foramen ovale: systematic review and meta-analysis. South Med J 2001; 94: 699-703.
Wahl A, Wincdecker S, Eberli FR, Seiler C, Meier B. Percutaneous closure of patent foramen ovale in symptomatic patients. J Interv Cardiol 2001;14: 203-209.
Donnan GA, Davis SM. Patent foramen ovale and stroke: closure by further randomized trial is required! Stroke 2004; 35: 806.
